The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravenous Iron Infusion Market Research Report 2025
Synopsis
Intravenous Iron Infusion can quickly provide a large amount of iron to directly enter the circulatory system, thereby promoting the production of red blood cells and repairing the symptoms of anemia caused by iron deficiency. This treatment is usually administered by a doctor in a medical facility or clinic, with the dose and frequency of injections determined according to the patient's specific situation and needs.
Global Intravenous Iron Infusion market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Iron Infusion market research.
Key manufacturers engaged in the Intravenous Iron Infusion industry include Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Vifor (International), Pharmacosmos, Nippon Shinyaku, Sanofi, AbbVie and Fresenius Kabi, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intravenous Iron Infusion were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous Iron Infusion market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intravenous Iron Infusion market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Vifor (International)
Pharmacosmos
Nippon Shinyaku
Sanofi
AbbVie
Fresenius Kabi
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Iron Isomaltosid
Others
Segment by Application
Gastroenterology
Oncology
Cardiology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intravenous Iron Infusion report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Intravenous Iron Infusion can quickly provide a large amount of iron to directly enter the circulatory system, thereby promoting the production of red blood cells and repairing the symptoms of anemia caused by iron deficiency. This treatment is usually administered by a doctor in a medical facility or clinic, with the dose and frequency of injections determined according to the patient's specific situation and needs.
Global Intravenous Iron Infusion market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Iron Infusion market research.
Key manufacturers engaged in the Intravenous Iron Infusion industry include Allergan, AMAG Pharmaceuticals, Daiichi Sankyo, Vifor (International), Pharmacosmos, Nippon Shinyaku, Sanofi, AbbVie and Fresenius Kabi, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intravenous Iron Infusion were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous Iron Infusion market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intravenous Iron Infusion market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Allergan
AMAG Pharmaceuticals
Daiichi Sankyo
Vifor (International)
Pharmacosmos
Nippon Shinyaku
Sanofi
AbbVie
Fresenius Kabi
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Iron Isomaltosid
Others
Segment by Application
Gastroenterology
Oncology
Cardiology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intravenous Iron Infusion report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Intravenous Iron Infusion Market Overview
1.1 Product Overview and Scope of Intravenous Iron Infusion
1.2 Intravenous Iron Infusion Segment by Type
1.2.1 Global Intravenous Iron Infusion Market Value Comparison by Type (2023-2029)
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Iron Isomaltosid
1.2.6 Others
1.3 Intravenous Iron Infusion Segment by Application
1.3.1 Global Intravenous Iron Infusion Market Value by Application: (2023-2029)
1.3.2 Gastroenterology
1.3.3 Oncology
1.3.4 Cardiology
1.3.5 Others
1.4 Global Intravenous Iron Infusion Market Size Estimates and Forecasts
1.4.1 Global Intravenous Iron Infusion Revenue 2018-2029
1.4.2 Global Intravenous Iron Infusion Sales 2018-2029
1.4.3 Global Intravenous Iron Infusion Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intravenous Iron Infusion Market Competition by Manufacturers
2.1 Global Intravenous Iron Infusion Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intravenous Iron Infusion Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intravenous Iron Infusion Average Price by Manufacturers (2018-2023)
2.4 Global Intravenous Iron Infusion Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intravenous Iron Infusion, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Iron Infusion, Product Type & Application
2.7 Intravenous Iron Infusion Market Competitive Situation and Trends
2.7.1 Intravenous Iron Infusion Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Iron Infusion Players Market Share by Revenue
2.7.3 Global Intravenous Iron Infusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Iron Infusion Retrospective Market Scenario by Region
3.1 Global Intravenous Iron Infusion Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intravenous Iron Infusion Global Intravenous Iron Infusion Sales by Region: 2018-2029
3.2.1 Global Intravenous Iron Infusion Sales by Region: 2018-2023
3.2.2 Global Intravenous Iron Infusion Sales by Region: 2024-2029
3.3 Global Intravenous Iron Infusion Global Intravenous Iron Infusion Revenue by Region: 2018-2029
3.3.1 Global Intravenous Iron Infusion Revenue by Region: 2018-2023
3.3.2 Global Intravenous Iron Infusion Revenue by Region: 2024-2029
3.4 North America Intravenous Iron Infusion Market Facts & Figures by Country
3.4.1 North America Intravenous Iron Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intravenous Iron Infusion Sales by Country (2018-2029)
3.4.3 North America Intravenous Iron Infusion Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Iron Infusion Market Facts & Figures by Country
3.5.1 Europe Intravenous Iron Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intravenous Iron Infusion Sales by Country (2018-2029)
3.5.3 Europe Intravenous Iron Infusion Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Iron Infusion Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Iron Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intravenous Iron Infusion Sales by Country (2018-2029)
3.6.3 Asia Pacific Intravenous Iron Infusion Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intravenous Iron Infusion Market Facts & Figures by Country
3.7.1 Latin America Intravenous Iron Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intravenous Iron Infusion Sales by Country (2018-2029)
3.7.3 Latin America Intravenous Iron Infusion Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Iron Infusion Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Iron Infusion Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intravenous Iron Infusion Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intravenous Iron Infusion Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Iron Infusion Sales by Type (2018-2029)
4.1.1 Global Intravenous Iron Infusion Sales by Type (2018-2023)
4.1.2 Global Intravenous Iron Infusion Sales by Type (2024-2029)
4.1.3 Global Intravenous Iron Infusion Sales Market Share by Type (2018-2029)
4.2 Global Intravenous Iron Infusion Revenue by Type (2018-2029)
4.2.1 Global Intravenous Iron Infusion Revenue by Type (2018-2023)
4.2.2 Global Intravenous Iron Infusion Revenue by Type (2024-2029)
4.2.3 Global Intravenous Iron Infusion Revenue Market Share by Type (2018-2029)
4.3 Global Intravenous Iron Infusion Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intravenous Iron Infusion Sales by Application (2018-2029)
5.1.1 Global Intravenous Iron Infusion Sales by Application (2018-2023)
5.1.2 Global Intravenous Iron Infusion Sales by Application (2024-2029)
5.1.3 Global Intravenous Iron Infusion Sales Market Share by Application (2018-2029)
5.2 Global Intravenous Iron Infusion Revenue by Application (2018-2029)
5.2.1 Global Intravenous Iron Infusion Revenue by Application (2018-2023)
5.2.2 Global Intravenous Iron Infusion Revenue by Application (2024-2029)
5.2.3 Global Intravenous Iron Infusion Revenue Market Share by Application (2018-2029)
5.3 Global Intravenous Iron Infusion Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Intravenous Iron Infusion Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 AMAG Pharmaceuticals
6.2.1 AMAG Pharmaceuticals Corporation Information
6.2.2 AMAG Pharmaceuticals Description and Business Overview
6.2.3 AMAG Pharmaceuticals Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AMAG Pharmaceuticals Intravenous Iron Infusion Product Portfolio
6.2.5 AMAG Pharmaceuticals Recent Developments/Updates
6.3 Daiichi Sankyo
6.3.1 Daiichi Sankyo Corporation Information
6.3.2 Daiichi Sankyo Description and Business Overview
6.3.3 Daiichi Sankyo Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Daiichi Sankyo Intravenous Iron Infusion Product Portfolio
6.3.5 Daiichi Sankyo Recent Developments/Updates
6.4 Vifor (International)
6.4.1 Vifor (International) Corporation Information
6.4.2 Vifor (International) Description and Business Overview
6.4.3 Vifor (International) Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Vifor (International) Intravenous Iron Infusion Product Portfolio
6.4.5 Vifor (International) Recent Developments/Updates
6.5 Pharmacosmos
6.5.1 Pharmacosmos Corporation Information
6.5.2 Pharmacosmos Description and Business Overview
6.5.3 Pharmacosmos Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pharmacosmos Intravenous Iron Infusion Product Portfolio
6.5.5 Pharmacosmos Recent Developments/Updates
6.6 Nippon Shinyaku
6.6.1 Nippon Shinyaku Corporation Information
6.6.2 Nippon Shinyaku Description and Business Overview
6.6.3 Nippon Shinyaku Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Nippon Shinyaku Intravenous Iron Infusion Product Portfolio
6.6.5 Nippon Shinyaku Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Intravenous Iron Infusion Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AbbVie Intravenous Iron Infusion Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Fresenius Kabi
6.9.1 Fresenius Kabi Corporation Information
6.9.2 Fresenius Kabi Description and Business Overview
6.9.3 Fresenius Kabi Intravenous Iron Infusion Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Fresenius Kabi Intravenous Iron Infusion Product Portfolio
6.9.5 Fresenius Kabi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Iron Infusion Industry Chain Analysis
7.2 Intravenous Iron Infusion Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Iron Infusion Production Mode & Process
7.4 Intravenous Iron Infusion Sales and Marketing
7.4.1 Intravenous Iron Infusion Sales Channels
7.4.2 Intravenous Iron Infusion Distributors
7.5 Intravenous Iron Infusion Customers
8 Intravenous Iron Infusion Market Dynamics
8.1 Intravenous Iron Infusion Industry Trends
8.2 Intravenous Iron Infusion Market Drivers
8.3 Intravenous Iron Infusion Market Challenges
8.4 Intravenous Iron Infusion Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
